Home » Clinical Trials » Solid tumors » NCT06501183
NCT06501183

Exploratory Study to Evaluate the Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors

Study Summary

This is a single-arm, open-label, exploratory clinical study to evaluate the safety and preliminary efficacy of Anti-CDH17 CAR-T cell injection in patients with CDH17-positive advanced malignant solid tumors.

Interested in this trial?

Submit an Inquiry

Interventions

Anti-CDH17 CAR-T cellsBIOLOGICAL
Anti-CDH17 CAR-T cell injection will be administered intravenously after lymphodepleting.

Study Locations

FacilityCityStateCountry
Shanghai Pudong hospitalShanghaiShanghai MunicipalityChina

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: May 29, 2026